NICE rejects Amgen’s Repatha in draft guidance
November 18, 2015Research and Development, Sales and Marketing Amgen, NICE, Repatha, evolocumab, high cholesterol
NICE has published draft guidance rejecting Amgen’s Repatha as a treatment for people with high cholesterol.
Challenges in oncology R&D
November 18, 2015Manufacturing and Production, Research and Development Dixie-Lee Esseltine, Takeda, Takeda oncology, Velcade, multiple myeloma, oncology
Pharmafile put questions on the challenges pharma companies face when working in oncology R&D to Dixie-Lee Esseltine, vice president of …
FDA accepts regulatory submission for Novartis biosimilar
November 18, 2015Research and Development, Sales and Marketing Neulasta, Novartis, Sandoz, biosimilar, pegfilgrastim
Novartis’ generics unit Sandoz has announced it has had its Biologics License Application (BLA) for a proposed biosimilar to Amgen’s …
Global drug spending will rise 30% by 2020, to $1.4 trillion
November 18, 2015Research and Development IMS Health, OTC, drug spending, emerging markets, generics, prescribing
Global spending on drugs will increase 30% to $1.4 trillion by 2020, as more patients get access to treatments and …
Scientists make possible pancreatic cancer discovery
November 18, 2015Research and Development Pancreatic cancer
Cancer researchers say they have discovered a potential new method of treatment for pancreatic cancer that could improve survival rates. …
UCB appoints Steve Turley as MD for Britain and Ireland
November 18, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing UCB
Steve Turley has joined UCB as the company’s managing director for the British and Irish isles, moving from Lundbeck. He …
Norgine opens new £4.5 million warehouse
November 17, 2015Manufacturing and Production, Research and Development Norgine, Temperature control, Wales, manufacturing, production, temperature-control
Norgine has opened a new £4.5 million temperature controlled warehouse on its current site in Hengoed, Wales. The Dutch-based firm …
Crescendo Biologics appoints Dr Kevin Johnson as chairman
November 17, 2015Research and Development
Crescendo Biologics, the drug discovery and developer of Humabody VH therapeutics, has announced the appointment of Dr Kevin Johnson as non-executive …
Catalent forced to suspend production after possible employee product sabotage
November 17, 2015Manufacturing and Production
Catalent has been forced to halt production at one of its French softgel capsule factories after the US-based manufacturer identified …
AbbVie rules out joining the biosimilars bandwagon
November 17, 2015Manufacturing and Production, Research and Development
AbbVie says it has ruled out moving into the biosimilars market to stave off competition once its blockbuster drug Humira …
FDA approves ‘first of its kind’ blood cancer drug
November 17, 2015Manufacturing and Production, Research and Development
The FDA has approved Genmab’s drug Darzalex for patients with multiple myeloma. Darzalex (daratumumab) is the first human CD38 monoclonal antibody …
DJM PAN Unlimited adds client services director
November 17, 2015Manufacturing and Production, Sales and Marketing
Wyndham Clark has joined the board of DJM PAN Unlimited as client services director. Previously, Clark was client services director …
NICE rejects Roche’s Kadcyla for NHS; price still too high
November 17, 2015Manufacturing and Production, Sales and Marketing Cancer Drugs Fund, Kadcyla, NHS England, NICE, Roche
NICE has published final draft guidance on Roche’s Kadcyla as a breast cancer treatment, deciding that the drug’s price remains …
Featured Market Report: Type 2 Diabetes – Epidemiology Forecast to 2024
November 16, 2015Manufacturing and Production, Research and Development diabetes, market reports
Diabetes is one of the most common non-communicable diseases worldwide and is an escalating public health problem globally, with an …
Pharma boss in sexism storm
November 16, 2015Immuno Biotech CEO David Noakes has been found guilty of sexual discrimination after making notes on the job application of …
FDA approves Baxalta Haemophilia A treatment
November 16, 2015Manufacturing and Production, Research and Development, Sales and Marketing
The US FDA has approved Baxalta’s twice-weekly therapy Adynovate for use in adults and adolescents, aged 12 years plus, with …
Former Health Secretary Andrew Lansley takes on Roche advisory role
November 16, 2015Medical Communications, Sales and Marketing
Former UK health secretary Andrew Lansley has taken on work as an advisor to Roche in the midst of ongoing …
Novo Nordisk invests $20m in diabetes research following study
November 16, 2015Research and Development, Sales and Marketing
Novo Nordisk has unveiled plans to combat urban diabetes in a $20 million investment offering expert resources and research funds …
Amgen’s Humira biosimilar succeeds in Phase III arthritis study
November 16, 2015Research and Development, Sales and Marketing Amgen, Humira
Amgen says its Humira (adalimumab) biosimilar candidate ABP 501 proved its clinical equivalence to Abbvie’s blockbuster drug in a head-to-head …
Takeda UK strengthens its senior leadership team
November 16, 2015Medical Communications, Sales and Marketing
Takeda UK is bolstering its Medical and Human Resources functions as Takeda continues to develop its expertise in the Specialty …
Latest content
Ofichem acquires US drug substance CDMO Kinentia
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ
Tridem begins phase Ib trial of Parkinson’s disease vaccine
